NM_003904.5:c.*724C>G

Variant summary

Our verdict is Likely benign.
-4 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -4 classification points (ACGS-UK Somatic Oncogenicity v2025). B1_Strong

The NM_003904.5(ZPR1):c.*724C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.823 (AC=125,282) in the gnomAD database across 152,238 control chromosomes, including 51,799 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.856. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.82 ( 51773 hom., cov: 32)
Exomes 𝑓: 0.88 ( 26 hom. )

Consequence

ZPR1
NM_003904.5 3_prime_UTR

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.346

Publications

541 publications found
Variant links:
Genes affected
ZPR1 (HGNC:13051): (ZPR1 zinc finger) The protein encoded by this gene is found in the cytoplasm of quiescent cells but translocates to the nucleolus in proliferating cells. The encoded protein interacts with survival motor neuron protein (SMN1) to enhance pre-mRNA splicing and to induce neuronal differentiation and axonal growth. Defects in this gene or the SMN1 gene can cause spinal muscular atrophy. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2015]
ZPR1 Gene-Disease associations (from GenCC):
  • growth restriction, hypoplastic kidneys, alopecia, and distinctive facies
    Inheritance: AR Classification: MODERATE Submitted by: PanelApp Australia

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_003904.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_benign. The variant received -4 points.

B1High frequency in general population
GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.856 — exceeds 1% threshold (B1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_003904.5. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

ZPR1 NM_003904.5
MANE Select
HGVSc / HGVSpc.*724C>G
Exon rankExon 14 of 14
3_prime_UTR
Prot: NP_003895.1UniProt: O75312
ZPR1 NM_001317086.2
HGVSc / HGVSpc.*724C>G
Exon rankExon 13 of 13
3_prime_UTR
Prot: NP_001304015.1

Ensembl Transcripts

ZPR1 ENST00000227322.8
TSL:1MANE Select
HGVSc / HGVSpc.*724C>G
Exon rankExon 14 of 14
3_prime_UTR
Prot: ENSP00000227322.3UniProt: O75312
ZPR1 ENST00000900046.1
HGVSc / HGVSpc.*724C>G
Exon rankExon 14 of 14
3_prime_UTR
Prot: ENSP00000570105.1UniProt: A0ACI8SFC3
ZPR1 ENST00000444935.5
TSL:5
HGVSc / HGVSpc.*724C>G
Exon rankExon 13 of 13
3_prime_UTR
Prot: ENSP00000390391.1UniProt: H7BZM7

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 5 sources
GnomAD3 genomes
AF: 0.823
AC:125152
Hom:51754
AN:152052
Cov:32
GnomAD4 exome
AF: 0.882
AC:60
Hom:26
AN:68
Cov:0
GnomAD4 genome
AF: 0.823
AC:125222
Hom:51773
AN:152170
Cov:32
TOPMed (Bravo)
AF: 0.813
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.850
AC:76593
Hom:32598
AN:90100
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.814
AC:1907
Hom:775
AN:2342
ChinaMAP Phase 1
AF: 0.786
Denmark Genome
AF: 0.837
AC:251
AN:300
GenomeAsia100K
AF: 0.765
AC:2662
AN:3478
Korea4K (4,157 Koreans)
AF: 0.776
AC:5609
AN:7230
Qatari Genome
AF: 0.807
AC:142
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.730
AC:89638
Hom:32789
AN:122814
Turkish Variome
AF: 0.809
AC:1251
Hom:508
AN:1546
UK10K
AF: 0.867
AC:6555
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.783
AC:7012
Hom:2759
AN:8960
Showing 15 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
SCHEMA
(Schizophrenia)
0.348 790222684 0.165 481829188
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign4.0
BayesDel_noAF
Benign-0.93
CADD
Benign0.48
DANN
Benign0.42
GPN-Star LLR
N/A3.7
GPN-Star score
N/A-0.76
Mutation Taster
N/A100/0polymorphism (auto)
PhyloP100
Benign-0.35
Showing 8 of 8 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.